Home / Guides / Compounded tirzepatide
Prescribed for you. Prepared by a licensed pharmacy.
Compounded tirzepatide: what it is and whether it’s safe
By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated
Compounded tirzepatide is made by a state-licensed pharmacy for one prescription and isn’t FDA-approved, so the FDA doesn’t review its safety (checked November 1, 2026). At NexLife, it’s $139 a month on the 12-month plan, or $169 month to month, the same at every dose.
$139/mo on 12 months, every dosePrice Match Guarantee†
- Not FDA-approved, and a different product from Zepbound
- Routine copies stopped in March 2025, after the shortage ended December 19, 2024
- $139 to $399 a month in our price index online; median $237 across 14 programs
Compounded tirzepatide at a glance
- What it is
- Tirzepatide prepared by a state-licensed 503A pharmacy for your prescription
- FDA status
- Not FDA-approved; Zepbound and Mounjaro are
- Who can get it
- A patient whose prescriber documents a significant difference for them, compared with an approved product
- Price online
- $139 to $399 a month in our price index at 14 programs (median $237)
- At NexLife
- $139 a month on the 12-month plan ($169 month to month), at every dose, all in
Not sure it’s right for you? Call or text
4.8 out of 5 on Trustpilot · LegitScript certified
About 3 minutes of health questions. No insurance needed.
Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.
At a glance
What to know about compounded tirzepatide in 2026
| Question | Answer |
|---|---|
| Is it safe? | The FDA doesn’t review it for safety, effectiveness or quality. It says to use one only when an approved drug can’t meet your needs |
| Is it legal in 2026? | Yes, when it’s compounded for you and your prescriber documents a significant difference. The shortage ended December 19, 2024 |
| How is it different from Zepbound? | Zepbound is FDA-approved and made by Eli Lilly. Compounded tirzepatide is made by a pharmacy for one patient, usually in a multiple-dose vial |
| What should the label show? | Your name, the strength in mg per mL, a beyond-use date and any added ingredient, such as B12 |
| How long can you use a vial? | The FDA says to throw out a multiple-dose vial 28 days after first use, even if some is left |
| What are the red flags? | No prescription, a pharmacy that won’t give its name, or “research use only” vials, which aren’t made for people |
- Tell us about you About 3 minutes of health questions
- A licensed provider decides You’re prescribed only if it’s right for you
- Your partner pharmacy ships Usually within 1 to 2 business days, free
Key takeaways
- Compounded tirzepatide: made by a state-licensed pharmacy for one patient. In our index, $139 to $399 a month (November 1, 2026).
- It isn’t FDA-approved, and it isn’t Zepbound or Mounjaro. The FDA doesn’t review it for safety, effectiveness or quality.
- Legal, with limits: the shortage ended December 19, 2024, so your prescriber must now document a significant difference for you.
- The FDA’s advice: get a prescription, use a state-licensed pharmacy, and throw out a multiple-dose vial 28 days after first use.
- Check the label for your name, the strength in mg per mL and a beyond-use date. Skip “research use only” products.
- At NexLife, compounded tirzepatide is $139 a month on the 12-month plan, or $169 month to month, at every dose.
Safety
Is compounded tirzepatide safe?
The FDA hasn’t checked: compounded drugs aren’t FDA-approved, so the FDA doesn’t review them for safety, effectiveness or quality before they’re sold. It says to use one only when an FDA-approved drug can’t meet a patient’s medical needs (checked November 1, 2026).
“Compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug.”
U.S. Food and Drug Administration, FDA’s Concerns with UnapprovedGLP-1 Drugs Used for Weight Loss
If you and your provider choose it, the FDA’s advice is practical:
- Get a prescription, and have it filled by a state-licensed pharmacy.
- Throw out a multiple-dose vial within 28 days of first use, even if some is left.
- Don’t use a vial that arrives warm or without enough cold packs.
- Measure your dose in milligrams, as prescribed. The FDA has reports of side effects tied to dosing mistakes with compounded
GLP-1 vials.
“The agency recommends patients not use any injectable
U.S. Food and Drug Administration, FDA’s Concerns with UnapprovedGLP-1 drug that arrives warm or with insufficient refrigeration, as this can affect the drug’s quality.”GLP-1 Drugs Used for Weight Loss
The FDA’s page on compounded
The basics
How is compounded tirzepatide different from Zepbound?
Two different products, and the differences matter. Here are the main ones; the full comparison is in our guide to compounded vs brand-name tirzepatide. Switching? See Zepbound to compounded tirzepatide.
| Compounded tirzepatide | Zepbound | |
|---|---|---|
| Made by | A state-licensed 503A pharmacy, for one patient’s prescription | Eli Lilly |
| FDA-approved | No | Yes |
| How it comes | Usually a multiple-dose vial you draw with a syringe | Single-dose pens and vials, 4-dose vials, or the 4-dose KwikPen |
| Self-pay price | $139 to $399 a month, month to month, in our price index. At NexLife: $139 a month on the 12-month plan, or $169 month to month, every dose | $299 to $449 a month at LillyDirect ($449 at 7.5 to 15 mg needs a refill within 45 days; otherwise $499 to $699) |
| Prescription | Yes, written for you | Yes |
Prices checked November 1, 2026. Paying less for compounded tirzepatide or semaglutide somewhere else? NexLife matches your regular monthly price.†
The rules
Is compounded tirzepatide legal in 2026?
Yes, when it’s compounded for you. Routine copies stopped after the FDA declared the shortage over on December 19, 2024, and a federal appeals court upheld that on August 27, 2026. A state-licensed 503A pharmacy may compound it for one patient when the prescriber documents a significant difference, such as a dose or form the approved product doesn’t offer.
Every rule and court date: is compounded tirzepatide legal?
“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”
What changed
What has changed for compounded tirzepatide since 2024?
The FDA and court decisions behind today’s rules, newest first, each with its source.
A federal appeals court, the Fifth Circuit, upholds the FDA’s decision that the tirzepatide shortage is over. U.S. Court of Appeals for the Fifth Circuit
By this date, the FDA had received more than 730 reports of adverse events associated with compounded tirzepatide. U.S. Food and Drug Administration
The FDA proposes excluding tirzepatide, semaglutide and liraglutide from the 503B bulks list, finding no clinical need. It will weigh comments before it decides. U.S. Food and Drug Administration
The FDA restates the conditions compounders must meet. Tirzepatide isn’t on its shortage list or the 503B bulks list. U.S. Food and Drug Administration
A federal court refuses to block the FDA’s shortage decision, and the grace period ends for 503A pharmacies. 503B outsourcing facilities get until March 19. U.S. Food and Drug Administration
After re-evaluating, the FDA decides the tirzepatide injection shortage is resolved. U.S. Food and Drug Administration
What should a compounded tirzepatide label show?
Your label should show your name, the strength in mg per mL and a beyond-use date, plus any added ingredient, such as B12. The FDA says to throw out a multiple-dose vial 28 days after first use (checked November 1, 2026). Missing one? Ask the program that prescribed it before you inject. More on added ingredients: tirzepatide with B12.
- Who prescribed it. A licensed provider who reviewed your history.
- Who made it. A named, state-licensed 503A pharmacy.
- What’s in it. Tirzepatide, its strength and a beyond-use date, on your label.
Who makes compounded tirzepatide at NexLife?
Two state-licensed 503A partner pharmacies: Absolute Pharmacy in Lutz, Florida, and Boudreaux’s New Drug Store in Lake Charles, Louisiana. Each prepares compounded tirzepatide for one patient’s prescription, after a licensed provider decides it’s right for you. Questions about a vial go to NexLife first, 24/7, and we follow up with the pharmacy for you.
- Named U.S. pharmacies. State-licensed 503A partner pharmacies: Absolute Pharmacy and Boudreaux’s New Drug Store.
- A licensed provider decides. Every prescription is a licensed provider’s call, never automatic.
- $139 a month on the 12-month plan, at every dose. Or $169 month to month. All in, with no membership. Paying less elsewhere? We match it.†
Real people, real answers. A question about your vial or your label? Ask us first. Call or text
Check my eligibilityCompounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.
Safety
How can you tell good compounded tirzepatide from a risky one?
A careful product comes with a prescription from a licensed provider, a named state-licensed 503A pharmacy, sterile compounding to USP 797 standards and a clear label. A risky one skips the prescription, hides the pharmacy or is sold as “research use only,” which isn’t made for people. Use the two lists below as your check.
- A prescription from a licensed provider who reviewed your history
- A named, state-licensed 503A pharmacy
- Sterile compounding to USP 797 standards
- A label with your name, the strength in mg per mL and a beyond-use date
- “Research use only” vials or powders, which aren’t made for people
- Any seller that skips the prescription or the provider
- A pharmacy that won’t tell you its name
Getting it
How to get compounded tirzepatide online
You need a prescription from a licensed provider, and a state-licensed pharmacy has to fill it. Online, that takes five steps, starting with a short health questionnaire. At NexLife, the questions take about 3 minutes, and if you aren’t prescribed, you aren’t charged for medication.
“Patients should obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy.”
U.S. Food and Drug Administration, FDA’s Concerns with UnapprovedGLP-1 Drugs Used for Weight Loss
Choose a licensed program.
A careful program has LegitScript certification, a published all-in price and a real number to call; NexLife has all three.
Answer the health questions.
About 3 minutes at NexLife.
Your provider decides.
A licensed provider reviews your history and prescribes only if it’s right for you.
A named pharmacy fills it.
At NexLife: Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA).
One number for everything after.
Call or text
(949) 818-8000 , 24/7. We follow up with the pharmacy for you.
6 questions to ask a compounded tirzepatide provider, with our answers
A clear offer answers each of these plainly. Here’s the market first, then our answer.
Is the medication FDA-approved or compounded?
Compounded tirzepatide isn’t FDA-approved; the FDA-approved versions are Zepbound and Mounjaro, and the FDA doesn’t review compounded drugs for safety, effectiveness or quality (checked November 1, 2026). At NexLife, it’s compounded tirzepatide, not Zepbound or Mounjaro, and we say so up front. A licensed provider decides whether it’s right for you.
What will I pay in month one, all in?
Online, compounded tirzepatide cost runs $139 to $399 a month in our price index, all in, and some programs start lower for a month (checked November 1, 2026). At NexLife, month one costs the same as every month: $139 on the 12-month plan, or $169 month to month. That covers care, medication, coaching and shipping.
Does the price go up with my dose?
At 9 of the 14 programs in our
GLP-1 price index, no: the price is the same at every dose (checked November 1, 2026). NexLife is one of them: $139 a month at 2.5 mg and at 15 mg on the 12-month plan, or $169 at each, month to month. Your price doesn’t change when your dose does.What if I pay less somewhere else?
Month to month, compounded tirzepatide runs $139 to $399 in our index (checked November 1, 2026). If you pay less with another licensed U.S. telehealth provider or clinic, send us a receipt from the last 60 days. We match your regular all-in monthly price while your plan stays active†, at every dose.
Which pharmacy fills my prescription?
One of two state-licensed 503A partner pharmacies: Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA). Both are named up front, not hidden. That matters: the FDA says to fill a prescription at a state-licensed pharmacy (checked November 1, 2026). A seller that won’t name its pharmacy is a red flag.
Who can I reach between visits?
Real people answer 24/7 at (949) 818-8000, by call or text, about your order or your vial. Physicians answer medical questions during clinical hours. We follow up with the pharmacy for you and get back to you, so you never have to chase anyone.
Vial math
How many units is your tirzepatide dose?
It depends on your vial’s strength. Here are the label’s doses at one example strength, with the math to check your own.
| Dose | mL at 25 mg/mL | Units (U-100) | On the label |
|---|---|---|---|
| 2.5 mg | 0.1 mL | 10 units | Starting dose, for 4 weeks |
| 5 mg | 0.2 mL | 20 units | A maintenance dose |
| 7.5 mg | 0.3 mL | 30 units | A step up |
| 10 mg | 0.4 mL | 40 units | A maintenance dose |
| 12.5 mg | 0.5 mL | 50 units | A step up |
| 15 mg | 0.6 mL | 60 units | The maximum, and a maintenance dose |
The math: mL = dose ÷ strength (mg per mL), and units = mL × 100. At 25 mg/mL, 10 mg is 10 ÷ 25 = 0.4 mL, or 40 units.
25 mg per mL is an example only: it’s the strength of the 15 mg multi-dose vial on Zepbound’s label (15 mg per 0.6 mL). Read the strength on your own vial’s label; your provider sets your dose, in steps at least 4 weeks apart. Every step: the tirzepatide dosage chart.
What would you pay with NexLife?
Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.
Pick one above to see your price.
Prices from each provider’s own site, checked November 1, 2026. Brand-name and compounded medications are different products: compounded medications aren’t FDA-approved, and a provider prescribes one only when it offers a significant difference for you. Price Match Guarantee† terms apply.
What does NexLife cost?
One flat price at every dose.
No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†
GIP + 12-month plan $139/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication
12-month plan $119/mo
Semaglutide
Weekly
Compounded, not FDA-approved · Not prescribed? No charge for medication
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms
The NexLife Price Match Guarantee†
Paying less elsewhere?
Keep your price. Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Compounded tirzepatide: your questions
Fair questions about NexLife
- Will my price go up with my dose?
- No. You pay the same at every dose.
- What if I’m not prescribed?
- You aren’t charged for medication.
- Can I cancel?
- Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
- Do I need insurance?
- No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.
What is compounded tirzepatide?
Tirzepatide prepared by a state-licensed pharmacy for one patient’s prescription, usually in a multiple-dose vial. It isn’t FDA-approved, and it isn’t Zepbound or Mounjaro. The vial may also hold a preservative or an added vitamin, listed on your label. Because the shortage ended on December 19, 2024, your prescriber must now document a significant difference for you.
Is compounded tirzepatide a GLP-1 ?
Yes, and more: tirzepatide acts on two hormone receptors, GIP and
How safe is compounded tirzepatide?
Its safety isn’t checked by the FDA: compounded drugs aren’t FDA-approved, and the FDA doesn’t review them for safety, effectiveness or quality (checked November 1, 2026). The FDA says to use one only when an approved drug can’t meet your medical needs, with a prescription filled by a state-licensed pharmacy. Avoid “research use only” products.
Is compounded tirzepatide still available in 2026?
Yes, for an individual patient when the prescriber documents a significant difference compared with an approved product. A state-licensed 503A pharmacy prepares it for that one prescription. Routine copies of Zepbound stopped after the shortage ended on December 19, 2024, a decision a federal appeals court upheld on August 27, 2026.
What are the FDA regulations on compounded tirzepatide?
A state-licensed 503A pharmacy may compound tirzepatide for one patient’s prescription, but not routine copies of Zepbound unless the prescriber documents a significant difference for that patient. A 503B outsourcing facility can’t make it from bulk tirzepatide, which is on neither the 503B bulks list nor the FDA’s shortage list. The FDA restated these rules on April 1, 2026.
Who makes compounded tirzepatide?
State-licensed 503A compounding pharmacies, each for one patient’s prescription. Eli Lilly makes Zepbound and Mounjaro, not compounded tirzepatide, and a 503B outsourcing facility can’t make it from bulk tirzepatide (checked November 1, 2026). At NexLife, two named, state-licensed partner pharmacies prepare it: Absolute Pharmacy (Lutz, FL) and Boudreaux’s New Drug Store (Lake Charles, LA).
Do you need a prescription for compounded tirzepatide?
Yes, always. A licensed provider has to review your history and decide it’s right for you, and a state-licensed pharmacy fills the prescription for you alone. Any seller that skips that step isn’t selling medicine, and “research use only” products aren’t made for people. At NexLife, the health questions take about 3 minutes.
How do I get compounded tirzepatide online?
Through a licensed telehealth program: you answer health questions, a licensed provider reviews your history and prescribes only if it’s right for you, and a named, state-licensed pharmacy fills it. At NexLife, the questions take about 3 minutes, and it’s $139 a month on the 12-month plan or $169 month to month, at every dose.
Is compounded tirzepatide an injection?
Usually, yes: a multiple-dose vial for a once-weekly injection, prepared by a state-licensed pharmacy for your prescription. It also comes as a sublingual tablet. At NexLife, the injection is $139 a month on the 12-month plan or $169 month to month; the tablet is $199 a month on the 12-month plan or $229 month to month.
What are the potential side effects of compounded tirzepatide?
On Zepbound’s label, the most common side effects include nausea, diarrhea, vomiting, constipation, stomach pain and indigestion. The FDA says many side effects reported with compounded versions look like those of the approved drug, though compounded tirzepatide wasn’t studied in trials. Questions? At NexLife, call or text (949) 818-8000, 24/7, or read what helps.
How much does compounded tirzepatide cost?
Online, $139 to $399 a month in our price index, all in, with a median of $237 across 14 programs (checked November 1, 2026). At NexLife, it’s $139 a month on the 12-month plan, or $169 month to month, the same at every dose.
Should you use “research use only” tirzepatide?
No. “Research use only” vials or powders aren’t made for people, and a seller that skips the prescription isn’t selling medicine. A careful product comes with a prescription from a licensed provider, a named state-licensed 503A pharmacy, sterile compounding to USP 797 standards and a clear label.
Has the FDA received reports of problems with compounded tirzepatide?
Yes. The FDA has received more than 730 reports of adverse events associated with compounded tirzepatide. It also has reports of side effects tied to dosing mistakes with compounded GLP-1 vials, so measure your dose in milligrams, as prescribed.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
Who wrote and medically reviewed this page?
Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.
Checked the FDA’s compounding rules and shortage decision, the Fifth Circuit ruling of August 27, 2026, and every price in our index.
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
Paying less elsewhere? We match it.†
Compounded tirzepatide, prescribed for you. $139 a month on 12 months at every dose.
$139 a month on a 12-month plan, or $169 month to month. About 3 minutes of health questions. A licensed provider decides if it’s right for you.
4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
- 1Tell us about you
Start online with your health history.
- 2A licensed provider decides
Online, following your state’s rules. You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.
Sources
- U.S. Food and Drug Administration. FDA’s concerns with unapproved
GLP-1 drugs used for weight loss. Checked November 1, 2026. - U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. Checked November 1, 2026.
- U.S. Food and Drug Administration. FDA clarifies policies for compounders as national
GLP-1 supply begins to stabilize. Checked November 1, 2026. - U.S. Court of Appeals for the Fifth Circuit. Outsourcing Facilities Association v. FDA, No. 25-10600 (Aug. 27, 2026).
- U.S. Pharmacopeia. USP General Chapter <797> Pharmaceutical Compounding: Sterile Preparations.
- Eli Lilly and Company. Zepbound through LillyDirect.
- AJMC. FDA approves monthly KwikPen option for tirzepatide in chronic weight management (February 23, 2026).
- LegitScript. LegitScript certification record for NexLife.us.
- NexLife. Compounded tirzepatide plans.
- Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
- Novo Nordisk. Wegovy (semaglutide) prescribing information.
- NexLife. Compounded semaglutide plans.
- Ro: weight loss program pricing. Checked November 1, 2026.
- Hims: Zepbound KwikPen. Checked November 1, 2026.
- Hims: Wegovy pill and pen, with membership. Checked November 1, 2026.
- Mochi Health: FAQs (membership and medication prices). Checked November 1, 2026.
- Embody: compounded tirzepatide, one-month supply. Checked November 1, 2026.
- Embody: compounded semaglutide, one-month supply. Checked November 1, 2026.
- U.S. Food and Drug Administration. FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List. April 30, 2026.